These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24185380)

  • 21. Synthesis and activity of isoxazoline vinyl ester pseudopeptides as proteasome inhibitors.
    Marastoni M; Scotti A; Trapella C; Ferretti V; Sforza F; Gavioli R
    J Pept Sci; 2014 Apr; 20(4):258-65. PubMed ID: 24677765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Novel Proteasome Inhibitors from an Enaminone Library.
    Elliott ML; Thomas K; Kennedy S; Koduri ND; Hussaini RS; Sheaff RJ
    Chem Biol Drug Des; 2015 Sep; 86(3):322-32. PubMed ID: 25494709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors.
    Troiano V; Scarbaci K; Ettari R; Micale N; Cerchia C; Pinto A; Schirmeister T; Novellino E; Grasso S; Lavecchia A; Zappalà M
    Eur J Med Chem; 2014 Aug; 83():1-14. PubMed ID: 24946214
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV protease inhibitors: synthesis and activity of N-aryl-N'-hydroxyalkyl hydrazide pseudopeptides.
    Marastoni M; Baldisserotto A; Trapella C; McDonald J; Bortolotti F; Tomatis R
    Eur J Med Chem; 2005 May; 40(5):445-51. PubMed ID: 15893018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based design of derivatives of tyropeptin A as the potent and selective inhibitors of mammalian 20S proteasome.
    Momose I; Umezawa Y; Hirosawa S; Iinuma H; Ikeda D
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1867-71. PubMed ID: 15780623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic studies of the branched chain amino acid preferring peptidase activity of the 20S proteasome: development of a continuous assay and inhibition by tripeptide aldehydes and clasto-lactacystin beta-lactone.
    McCormack TA; Cruikshank AA; Grenier L; Melandri FD; Nunes SL; Plamondon L; Stein RL; Dick LR
    Biochemistry; 1998 May; 37(21):7792-800. PubMed ID: 9601040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
    Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
    Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of lipopeptides for inhibiting 20S proteasomes.
    Basse N; Papapostolou D; Pagano M; Reboud-Ravaux M; Bernard E; Felten AS; Vanderesse R
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3277-81. PubMed ID: 16630721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of the PA28alpha-20S proteasome interaction by a peptidyl alcohol.
    Wilk S; Chen WE; Magnusson RP
    Arch Biochem Biophys; 1999 Feb; 362(2):283-90. PubMed ID: 9989937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.
    de Bruin G; Huber EM; Xin BT; van Rooden EJ; Al-Ayed K; Kim KB; Kisselev AF; Driessen C; van der Stelt M; van der Marel GA; Groll M; Overkleeft HS
    J Med Chem; 2014 Jul; 57(14):6197-209. PubMed ID: 25006746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structurally novel highly potent proteasome inhibitors created by the structure-based hybridization of nonpeptidic belactosin derivatives and peptide boronates.
    Kawamura S; Unno Y; Asai A; Arisawa M; Shuto S
    J Med Chem; 2014 Mar; 57(6):2726-35. PubMed ID: 24524217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Introduction of non-natural amino acid residues into the substrate-specific P1 position of trypsin inhibitor SFTI-1 yields potent chymotrypsin and cathepsin G inhibitors.
    Łegowska A; Debowski D; Lesner A; Wysocka M; Rolka K
    Bioorg Med Chem; 2009 May; 17(9):3302-7. PubMed ID: 19362846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and activity of tyropeptin A derivatives as potent and selective inhibitors of mammalian 20S proteasome.
    Momose I; Umezawa Y; Hirosawa S; Iijima M; Iinuma H; Ikeda D
    Biosci Biotechnol Biochem; 2005 Sep; 69(9):1733-42. PubMed ID: 16195592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel 20S proteasome inhibitors by rational topology-based scaffold hopping of bortezomib.
    Xu Y; Yang X; Chen Y; Chen H; Sun H; Li W; Xie Q; Yu L; Shao L
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2148-2152. PubMed ID: 29773504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of boron peptide analogues of Belactosin C as proteasome inhibitors.
    Nakamura H; Watanabe M; Ban HS; Nabeyama W; Asai A
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3220-4. PubMed ID: 19428245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel tamoxifen derivative, ridaifen-F, is a nonpeptidic small-molecule proteasome inhibitor.
    Hasegawa M; Yasuda Y; Tanaka M; Nakata K; Umeda E; Wang Y; Watanabe C; Uetake S; Kunoh T; Shionyu M; Sasaki R; Shiina I; Mizukami T
    Eur J Med Chem; 2014 Jan; 71():290-305. PubMed ID: 24321833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetogenic agent alloxan is a proteasome inhibitor.
    Zhou W; Wei L; Xiao T; Lai C; Peng M; Xu L; Luo X; Deng S; Zhang F
    Biochem Biophys Res Commun; 2017 Jun; 488(2):400-406. PubMed ID: 28502636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenoxypropanolamine derivatives as selective inhibitors of the 20S proteasome β1 and β5 subunits.
    Hovhannisyan AA; Pham TH; Bouvier D; Tan X; Touhar S; Mkryan GG; Dallakyan AM; El Amri C; Melikyan GS; Reboud-Ravaux M; Bouvier-Durand M
    Bioorg Med Chem Lett; 2017 Dec; 27(23):5172-5178. PubMed ID: 29113763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
    Stein RL; Melandri F; Dick L
    Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel aromatic sulfonyl naphthalene-based boronates as 20S proteasome inhibitors.
    Liu H; Wu J; Ge Y; Li A; Li J; Liu Z; Xu Y; Xu Q; Li Y
    Bioorg Med Chem; 2018 Mar; 26(5):1050-1061. PubMed ID: 29426629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.